title: Hsp72 mediates TAp73α anti-apoptotic effects in small cell lung carcinoma cells.
abstract: The transcription factor p73, a member of the p53 family of proteins, is involved in the regulation of cell cycle progression and apoptosis. Due to alternative promoters and carboxy-terminal splicing, the P73 gene gives rise to a range of different isoforms. Interestingly, a particular increase in expression of the TAp73α isoform has been reported in various tumours. In addition, TAp73α has been shown to inhibit Bax activation and mitochondrial dysfunctions and thereby to confer small cell lung carcinoma (SCLC) cells resistance to drug-induced apoptosis. However, the precise mechanism by which TAp73α exerts its pro-survival effect is yet unclear. Here we report that TAp73α, but not TAp73β, regulates the expression of inducible Hsp72/HSPA1A. Hsp72 proved to be required for the survival effects of TAp73α as antisense knockdown of Hsp72 resulted in an abolishment of the anti-apoptotic effect of TAp73α in SCLC cells upon Etoposide treatment. Importantly, depletion of Hsp72 allowed activation of Bax, loss of mitochondrial membrane potential and lysosomal membrane permeabilization in SCLC cells even in the presence of TAp73α. Finally, we revealed that TAp73β counteracts the anti-apoptotic effect of TAp73α by preventing Hsp72 induction. Our results thus provide additional evidence for the potential oncogenic role of TAp73α, and extend the understanding of the mechanism for its anti-apoptotic effect.
authors.affiliation: Department of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Ulrika
authors.initials: U
authors.lastname: Nyman
authors.forename: Naveen Reddy
authors.initials: NR
authors.lastname: Muppani
authors.forename: Boris
authors.initials: B
authors.lastname: Zhivotovsky
authors.forename: Bertrand
authors.initials: B
authors.lastname: Joseph
mesh_terms: D017398:Alternative Splicing; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D017209:Apoptosis; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D005047:Etoposide / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D057809:HEK293 Cells; D050884:HSP72 Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D015151:Immunoblotting; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D018613:Microscopy, Confocal; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D055752:Small Cell Lung Carcinoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000072160:Tumor Protein p73; D025521:Tumor Suppressor Proteins / Q000235:genetics / Q000378:metabolism*; D051028:bcl-2-Associated X Protein / Q000378:metabolism
chemical_list: D000972:Antineoplastic Agents, Phytogenic; C494826:BAX protein, human; D004268:DNA-Binding Proteins; D050884:HSP72 Heat-Shock Proteins; D009687:Nuclear Proteins; D020033:Protein Isoforms; C000606460:TP73 protein, human; D000072160:Tumor Protein p73; D025521:Tumor Suppressor Proteins; D051028:bcl-2-Associated X Protein; D049452:Green Fluorescent Proteins; D005047:Etoposide
references.citation: Cancer Res. 2008 Aug 15;68(16):6623-33
references.pmid: 18701486
references.citation: Cell Death Differ. 2002 Mar;9(3):237-45
references.pmid: 11859406
references.citation: Oncogene. 1999 Feb 25;18(8):1629-33
references.pmid: 10102633
references.citation: Oncogene. 2008 Oct 27;27(50):6434-51
references.pmid: 18955971
references.citation: Ann Oncol. 2001 Jul;12(7):981-6
references.pmid: 11521806
references.citation: Oncogene. 2003 May 22;22(21):3231-42
references.pmid: 12761493
references.citation: Nature. 1997 Sep 11;389(6647):191-4
references.pmid: 9296498
references.citation: J Exp Med. 2004 Aug 16;200(4):425-35
references.pmid: 15314073
references.citation: Cell Death Differ. 2001 Dec;8(12):1213-23
references.pmid: 11753569
references.citation: J Cell Mol Med. 2008 Jun;12(3):743-61
references.pmid: 18266962
references.citation: EMBO J. 1998 Nov 2;17(21):6124-34
references.pmid: 9799222
references.citation: J Nippon Med Sch. 2003 Jun;70(3):234-42
references.pmid: 12928725
references.citation: Cell Death Differ. 2007 Aug;14(8):1497-507
references.pmid: 17464323
references.citation: Cancer Res. 2002 Feb 1;62(3):636-41
references.pmid: 11830511
references.citation: J Exp Med. 1998 Nov 2;188(9):1763-8
references.pmid: 9802988
references.citation: Nat Cell Biol. 2001 Sep;3(9):839-43
references.pmid: 11533664
references.citation: Cancer Res. 2007 Mar 1;67(5):2373-81
references.pmid: 17332370
references.citation: J Biol Chem. 2005 Oct 7;280(40):34159-69
references.pmid: 16087678
references.citation: Biochem J. 2001 Jun 15;356(Pt 3):859-66
references.pmid: 11389695
references.citation: Cancer Res. 1999 Jun 15;59(12):2791-3
references.pmid: 10383132
references.citation: Cancer Res. 2005 Feb 1;65(3):758-66
references.pmid: 15705872
references.citation: Oncol Rep. 2007 Aug;18(2):447-50
references.pmid: 17611669
references.citation: Cancer Res. 2002 Dec 15;62(24):7139-42
references.pmid: 12499245
references.citation: Cancer Biol Ther. 2003 Nov-Dec;2(6):663-9
references.pmid: 14688473
references.citation: Mol Cell Biol. 2000 Oct;20(19):7146-59
references.pmid: 10982831
references.citation: J Biol Chem. 2000 Nov 17;275(46):36316-23
references.pmid: 10961991
references.citation: J Biol Chem. 2000 May 19;275(20):15226-31
references.pmid: 10809758
references.citation: FEBS Lett. 2001 Jan 26;489(1):4-7
references.pmid: 11231003
references.citation: Mol Cell Biol. 1998 Nov;18(11):6624-33
references.pmid: 9774677
references.citation: Cell. 1997 Aug 22;90(4):809-19
references.pmid: 9288759
references.citation: J Biol Chem. 2005 Jan 21;280(3):2159-64
references.pmid: 15545283
references.citation: Cancer Res. 1998 Nov 15;58(22):5061-5
references.pmid: 9823311
references.citation: Oncogene. 1999 Jul 22;18(29):4171-81
references.pmid: 10435630
references.citation: Clin Cancer Res. 2000 May;6(5):1767-71
references.pmid: 10815895
references.citation: Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7871-6
references.pmid: 10884417
references.citation: J Biol Chem. 2003 Aug 15;278(33):31401-11
references.pmid: 12782632
references.citation: Electrophoresis. 2001 Oct;22(18):4016-22
references.pmid: 11700735
references.citation: Cell Prolif. 2000 Dec;33(6):341-65
references.pmid: 11101008
references.citation: Exp Cell Res. 2000 May 25;257(1):58-66
references.pmid: 10854054
references.citation: J Biol Chem. 2005 Nov 18;280(46):38729-39
references.pmid: 16172114
references.citation: Exp Cell Res. 1996 Feb 25;223(1):163-70
references.pmid: 8635489
references.citation: Biochem Biophys Res Commun. 2004 May 7;317(3):865-72
references.pmid: 15081420
references.citation: J Biol Chem. 2004 Feb 27;279(9):8076-83
references.pmid: 14634023
references.citation: Biochim Biophys Acta. 2001 Dec 28;1552(2):47-59
references.pmid: 11825686
references.citation: Cancer Res. 2003 Sep 15;63(18):5829-37
references.pmid: 14522906
references.citation: Acta Neuropathol. 2007 Dec;114(6):641-50
references.pmid: 17912537
references.citation: Cell Death Differ. 2010 Jul;17(7):1167-78
references.pmid: 20094062
references.citation: Cancer Res. 2001 Feb 1;61(3):935-8
references.pmid: 11221886
references.citation: Int J Cancer. 1995 Mar 3;60(5):689-93
references.pmid: 7860144
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3529-34
references.pmid: 11891335
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1339-46
references.pmid: 16484678
references.citation: Oncogene. 1999 Jun 17;18(24):3648-51
references.pmid: 10380887
references.citation: Mol Cell Biol. 1997 Sep;17(9):5317-27
references.pmid: 9271409